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Background: Early referral and management of high-risk chronic kidney disease may prevent or delay the need for
dialysis. Automatic eGFR reporting has increased demand for out-patient nephrology consultations and in some
cases, prolonged queues. In Canada, a national task force suggested the development of waiting time targets,
which has not been done for nephrology.
Methods: We sought to describe waiting time for outpatient nephrology consultations in British Columbia (BC).
Data collection occurred in 2 phases: 1) Baseline Description (Jan 18-28, 2010) and 2) Post Waiting Time
Benchmark-Introduction (Jan 16-27, 2012). Waiting time was defined as the interval from receipt of referral letters to
assessment. Using a modified Delphi process, Nephrologists and Family Physicians (FP) developed waiting time
targets for commonly referred conditions through meetings and surveys. Rules were developed to weigh-in
nephrologists’, FPs’, and patients’ perspectives in order to generate waiting time benchmarks. Targets consider
comorbidities, eGFR, BP and albuminuria. Referred conditions were assigned a priority score between 1-4. BC
nephrologists were encouraged to centrally triage referrals to see the first available nephrologist. Waiting time
benchmarks were simultaneously introduced to guide patient scheduling. A post-intervention waiting time
evaluation was then repeated.
Results: In 2010 and 2012, 43/52 (83%) and 46/57 (81%) of BC nephrologists participated. Waiting time decreased
from 98(IQR44,157) to 64(IQR21,120) days from 2010 to 2012 (p = <.001), despite no change in referral eGFR,
demographics, nor number of office hrs/wk. Waiting time improved most for high priority patients.
Conclusions: An integrated, Provincial initiative to measure wait times, develop waiting benchmarks, and engage
physicians in active waiting time management associated with improved access to nephrologists in BC.
Improvements in waiting time was most marked for the highest priority patients, which suggests that benchmarks
had an influence on triaging behavior. Further research is needed to determine whether this effect is sustainable.
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Delays in access to medical services are an important
issue for publicly funded health systems. In Canada, 57%
of patients waited more than four weeks for a specialist
appointment in 2004, which is worst among Australia
(46%), the United Kingdom (40%), Germany (23%) and
New Zealand (22%) [1]. Such barriers within the primary to
specialist care-continuum may prolong exposure to time-
sensitive disease in the absence of expert management.
The Canadian government addressed the problem of
delayed access to healthcare in 2004 through the $5.5
billion Wait Times Reduction Fund [2]. The program’s
objective was to reduce delays for medical procedures,
cancer treatment, and diagnostic imaging. The interval
of waiting that it targeted is the period between book-
ing procedures and their completion, which is known as
waiting time 2 [3,4]. The preceding period of delay, be-
tween referral and first assessment by a specialist, is known
as waiting time I. Waiting time I is the greatest concern for
family physicians, among whom 50% consider it unac-
ceptably long [5]. The Canadian Medical Association and
Health Canada began efforts to address waiting time I in
2010. A toolkit for streamlining referral processes was de-
veloped, and a resource to highlight current referral reform
projects has been compiled (http://www.cma.ca/referrals).
Chronic kidney disease (CKD) is prevalent with approxi-
mately 2 million Canadians affected [6], and for patients
with progressive CKD, timely access to nephrologists is
vital. Early management of high risk CKD by a nephrologist
has been shown to slow progression to End Stage Renal
Disease (ESRD) [7-13]. Recent implementation of auto-
matic estimated glomerular filtration rate (eGFR) reporting
by laboratories in Canada and abroad has improved screen-
ing, but increased the volume of both appropriate and in-
appropriate referrals, which likely prolongs queues [14-16].
Current guidelines make suggestions regarding who should
be referred to a nephrologist, but do not indicate appropri-
ate timeframes for assessment [17].
In 2006, the Federal Advisor on Wait times recom-
mended the development of targets for appropriate wait-
ing [18]. This process has been undertaken for paediatric
nephrology, though not for adult kidney disease, which is
more prevalent [19]. The BC Nephrologists’ Access Study
(BCNAS) was designed as a Provincial collaboration to
study wait time I. We conceived of a change management
strategy based on physician engagement and wait time
benchmark development. We hypothesized that involving
local physician stakeholders in generating consensus wait-
ing time I benchmarks, would reduce the wait for out-
patient nephrology consultations. To test the hypothesis,
we: 1) Conducted an environmental scan to measure wait
times in the Province; 2) Engaged nephrologists and refer-
ring physicians to develop maximally-recommended wait
time targets; 3) Encouraged pooled triage (patients assignedto first-available nephrologist in group practice) where pos-




The BCNAS was a prospective, pre-, post-intervention,
interrupted time-points observational, design. Data collec-
tion was performed over two-cycles (January 18–28, 2010
and January 16–27, 2012) to determine the impact of the
intervention on wait times. Physician, region, and patient
anonymity were maintained. BCNAS was approved by the
University of British Columbia Research Ethics Board.
Setting and participants
We sought to collect data from the 12 nephrology practice
groups in British Columbia (BC). Provincial nephrologists
collectively service an estimated catchment population of
4.6 million people as of July 01, 2011 [20]. All nephrolo-
gists in BC are affiliated with one of the 12 groups, which
are organized within the Provincial health system into 5
geographic Health Authorities (HA). The BC Provincial
Renal Agency (BCPRA) oversees administration of renal
services in the Province. Representative nephrologists and
administrators from all 5 Health Authorities sit on the
BCPRA Executive and Medical Advisory Committees
(MAC), which meet regularly. Using this infrastructure it
is possible to undertake Provincial Initiatives, which span
health regions. Data for our study was thereby collated
and analyzed centrally by BCPRA statisticians. Nephrolo-
gists who agreed to participate allowed their private office
Medical Office Assistants (MOAs) to perform data-entry.
MOA participation was recognized with an honorarium.
Data collection
Standardized data collection forms were used to abstract
information about nephrologists’ practices as well as de-
mographic and clinical data pertaining to new patients.
Specifically, we recorded patients’ age and sex, renal func-
tion, proteinuria, reason for referral, and how many times
they were re-booked before being seen. Nephrologist par-
ticipation and study structure are outlined in Figure 1. To
allow inferences about planned and actual wait times, a
distinction was made between 2 types of new patients that
were identified during the 2-week study window. New
patients were defined as those not previously known to
the nephrologist, or those last seen more than 24 months
ago. Wait times were defined as the interval between fax
receipt of the referral letter and assessment of the patient.
Factors presumed to impact upon Provincial wait times
are shown in Figure 2.
Reasons for referral were indicated by MOAs on the
data-collection form. This information was confirmed
through manual audit by a nephrologist (MS) and used
Figure 1 Study timeline.
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patients referred from another nephrologist for transfer
of care were considered new, because they required a
full consultation, but were not placed into a priority cat-
egory because dialysis therapy is presumed to be on-
going and therefore less time-sensitive.Figure 2 Schematic representation of multiple factors that may impaIntervention
The intervention consisted of a physician-led Provincial
initiative with goals to measure wait times, develop max-
imally recommended wait time targets, and promote
targeted reductions if needed. The wait time issue was
broached using an initial presentation and preliminaryct upon provincial out-patient nephrology waiting time.
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ogists’ consensus meeting in November 2009.
Through further face-to-face meetings and surveys, we
used an iterative process modeled on the modified Delphi
technique. Input from stakeholders including BC nephrol-
ogists and Family Physicians (FP) was used together to de-
velop condition-specific wait time recommendations. This
process also stimulated an ongoing Provincial dialogue on
wait times, which included advancing use of pooled triage
and telephone advice for non-progressive kidney disease.
Following the pre-intervention, environmental scan (first
MOA data-collection cycle Jan 18–28, 2010) the most com-
mon reasons for referral were identified and used to de-
velop two physician surveys: one for nephrologists and the
second for FPs. The nephrologist survey was administered
at the 2010 BC Nephrology Days meeting, which the ma-
jority of provincial Nephrologists attend. Non-attendees
were asked to participate online. Nephrologists were asked
to suggest appropriate wait times for common referral cat-
egories, 1st from the physician’s medical perspective, and
then to assume the perspective of a patient. This was done
to weigh-in the patient’s unmeasured burden of waiting
when they have been told they need to see a kidney
specialist.
The other survey was given to FPs attending a one-day
course in nephrology. It was identical to the survey given
to nephrologists, except did not ask FPs to assume the pa-
tient’s perspective. This was done to weigh-in the need for
timely management advice among referral-base colleagues.
The following rules were developed by the study inves-
tigators (MS, MB and AL) to be used to develop waiting
time I benchmarks:
1. Use the median nephrologists’ medically recommended
wait time except when rules 2 or 3 apply.
2. If >1/3 of nephrologists revised wait times
downward when asked to assume the patient’s
perspective, reduce benchmark one wait time
category sooner.
3. If 50% of GPs believe the wait should be shorter
than determined by rules 1 and 2, revise 1 wait time
category sooner.
With this strategy, 4 priority categories were developed
for out-patient nephrology cases. Priority I includes refer-
rals that should be seen within 3 weeks; priority 2 within
6 weeks; priority 3 within 12 weeks; and, priority 4 within
24 weeks.
Once the prioritization process was completed, to con-
firm consensus, the final step in our iterative bench-
marking method included approval of benchmarks by BC
Nephrologists at the BCPRA Medical Advisory Committee
meeting (June 3, 2011). These benchmarks were then dis-
tributed to all BC Nephrologists. In December 2011 all BCnephrologists were contacted to remind them of the max-
imally recommended waiting time benchmarks. The ma-
jority of physicians had participated in the benchmarking
exercise. Hard-copies of the recommendations were pro-
vided with the study package for the (post-intervention)
2nd MOA survey to serve as a reference sheet to be used
during triage of new referrals.
Outcome measures
The primary outcome was the proportion of new patients
that were seen within recommended wait time targets.
Additional metrics included the change in wait times fol-
lowing introduction of Provincial wait time targets, and
the change in planned wait time (at the time the referral
request is received). Descriptive statistics pertaining to
Provincial nephrology referrals and an analysis of regional
variability in wait times and referral acuity were also pre-
determined.
Statistical analysis
The underlying distributions of continuous variables were
assessed using the Shapiro-Wilk test for normality. None of
the continuous variables were normally distributed; hence,
they are presented as median with interquartile range.
Comparisons were made via the Wilcoxon χ2-test. Statis-
tical software used was SAS, version 9.1 (SAS Institute,
Cary, NC, USA).
Results
Nephrologists and family physicians
Nephrologist participation included 43 of 52 (83%) in
2010 and 46 of 57 (81%) in 2012 (Figure 1). Ten of 12
(83%) nephrology practice groups had at least one mem-
ber participate in 2010 and 2012 MOA data-collection
cycles. Among 2012 nephrologist respondents, 83% had
also participated in 2010. Table 1 shows characteristics
of participating nephrologists as well as referred patients.
Thirty-five of 43 FPs (81%) attending a one-day course
in Nephrology participated in the FP survey.
Nephrologists allocated a mean 8.1 (standard deviation,
5.9) hours per week to office practice with no difference
between 2010 and 2012. New consults were allotted a me-
dian 60 (45–60) and follow-ups 23 (15–30) minutes. The
median ratio of follow-up patients for each new patient
seen was 4.08 (IQR 2.5-8.3) and 4.5 (IQR 2.2-8.3) in 2010
and 2012, respectively (p = 0.92). 27% (124/454) of patients
seen in the office during the study periods experienced de-
lays due to rescheduling. Overall, rescheduling was more
often due to patients cancelling or re-scheduling (55%).
Cases where the doctor re-scheduled were more common
in 2010 (52%) than 2012 (34%) (p = 0.052). In 2012, 59%
of BC nephrologists participated in a pooled triage sys-
tem, wherein consults are assigned to the first-available
Table 1 Characteristics of nephrologists and patients
referred in 2010 and 2012
Group, characteristic 2010 2012 p value
Nephrologists n = 43 n = 46 –
Age, yr (%)*
<40 - 37





301−500 16 35 P < 0.001
>500 75 28
Patients n = 518 n = 402
New referral requests 251 215 –
New patients seen 267 187
Age, yr (%)
<50 15 16
50−64 28 29 0.889
65−79 35 37
≥80 21 19
Sex, female (%) 51 49 0.555
Referral eGFR, mL/min per 1.73 m2 (%)
<30 18 16
30−60 65 61 0.044
>60 17 23
* Nephrologist’s age was not collected in 2010 survey.
Table 2 Primary care physicians’ (FP) and nephrologists’ wait
Nephrology condition
Median wait time r
(FP, n = 35)
CKD eGFR < 30 <3
Uncontrolled hypertension 3−6
New dipstick positive proteinuria (no diabetes) 3−6
Diabetic nephropathy eGFR < 45 3−6
Diabetic nephropathy, eGFR ≥ 45 6−12
Recurrent nephrolithiasis 6−12
CKD, eGFR 30-45 6−12
New diagnosis PCKD, normal eGFR 12−24
Microalbuminuria, non-diabetic, normal eGFR 12−24
CKD, eGFR 46-60 12−24
Isolated microscopic hematuria Telephone
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10% of nephrologists used central triage in 2010.
Wait time benchmark development
Table 2 describes nephrologist and FP responses when
asked to suggest maximal appropriate wait times for the
11 referral categories. When nephrologists were asked to
shift between medical and patient perspectives, wait time
recommendations were revised downward in 39% of re-
sponses. Condition-specific, maximally recommended
wait time targets are shown in Table 3.
Waiting times
A total of 920 patients were included in the analysis.
The median wait time decreased 35% from 98 (IQR 44–
157) days in 2010 to 64 (IQR 21–120) days in 2012 (p =
0.0002). The median planned wait time decreased 68%,
from 90 (IQR 23–139) to 29 (IQR 14–74) days (p <
0.0001). Median eGFR did not change during the waiting
period in either 2010 (+ 0.59 ml/min/m2; IQR −0.44-
2.45) or 2012 (+ 0.53 ml/min/m2; IQR −0.97-3.44).
Figure 3 shows the proportion of new referrals that
were seen within the recommended maximal wait period
in 2010 as compared to 2012.
Since the hire of additional nephrologists might be
expected to reduce wait times, through diluting the de-
mand for services among more physicians, we examined
wait times within health authorities that both added and
did not add nephrologists. Results are shown in Table 4.
There was no correlation between addition of nephrolo-
gists and reduction in wait time.
Discussion
In this study, we implemented a Provincial change strategy,
which invested physicians in the wait time managementtime recommendations
ecommendation (weeks) Proportion of nephrologists
who reduced wait time
recommendation ≥ 1 category when
switching to patient’s perspective (%)












Table 3 Recommended timeframe for nephrology assessment‡
Priority Nephrology conditions Wait time
target (weeks)
1. Immediately threatening renal disease –
Requires rapid access
Acute kidney injury, suspected vasculitis/glomerulonephritis
or Nephrotic Syndrome, eFGR < 15 ml/min
<3
2. High risk renal disease – Requires expedited
access to prevent adverse outcomes
Diabetic nephropathy eGFR < 45 (ACr > 30 or dipstick positive) 3−6
New onset dipstick positive proteinuria (or repeat ACRs > 30) 3−6
CKD, eGFR < 30* 3−6
Uncontrolled hypertension 3−6
3. Stable renal disease – Requires timely access Recurrent nephrolithiasis 6−12
Isolated microscopic hematuria 6−12
CKD, eGFR 30-45 6−12
New Diagnosis PCKD, normal eGFR 6−12
Overt Diabetic nephropathy eGFR > 45 6−12
4. At risk kidneys – Limited empirical evidence that
nephrology assessment mproves outcomes
CKD, eGFR 46-60 12−24
Microalbuminuria, non DM, normal eGFR 12−24
‡ Telephone or other non-traditional modalities for advice may be considered as an alternative to a full office consultation at the discretion of the nephrologist.
*Median Wait Time recommended by General Practitioners fell in the < 3 wk category. In the absence of urgent features (very low GFR, rapid loss of renal
function, active urine sediment, uremic symptoms, etc), such patients can safely be seen within a timeframe of 3-6 weeks.
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duction in waiting for out-patient nephrologist consulta-
tions. Multiple factors may influence wait time dynamics,
including time-varying referral rates, number of nephrolo-
gists, pooled versus individual triage systems, and practice
sizes (Figure 2). We found that the proportion of patients
seen within the recommended timeframes improved in the
interval spanning the 2010 and 2012 data collection cycles.
The fact that the magnitude of improvement aligned with
referral priority (the greatest percentage reduction in wait
times was for priority 1 patients), suggests that our inter-
vention exerted an influence over nephrologists’ triaging
behavior.Figure 3 The greatest improvement in achieving recommended wait
proportion of patients in 2010 compared to 2012 waiting less than reThe 35% reduction in actual wait times (from median
98 to 64 days) was proportionately greater than the 22%
reduction in total referrals (from 518 to 402, Table 1),
which refutes the possibility that a reduction in referral
rate fully accounts for the change in wait times. The rea-
sons for observing a lower referral rate are unknown,
but seasonal variation is not implicated because the
post-implementation data collection was done over the
same annual two-week period in both instances. On-
going efforts to educate referring physicians about ap-
propriate nephrology consultation criteria could have
played a role in reducing referrals, but this effect has not
been measured.times was made for the highest priority patients (p-values are for
commended benchmark within each priority category).
Table 4 Change in actual wait times within health















1 0 105 44 −58%
2 +1 91 95 +4%
3 +1 97 65 −33%
4 +1 267 13 −95%
5 +2 74 42 −43%
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Province between 2010 and 2012, which could have im-
pacted upon wait times. However, Health authority 1 ex-
perienced a near 60% reduction in wait time, despite no
net change in the number of nephrologists between
2010 to 2012, while health authority 2 had wait times in-
crease 4% despite adding a nephrologist. Health author-
ities in BC are mostly closed systems with respect to
patient flow, thus it is likely that nephrologist flux did
not have a major impact on wait times.
With respect to triage practices, 60% of BC nephrologists
had adopted the first-available nephrologist (pooled) triage
model between 2010 and 2012. It is possible that efficien-
cies related to this practice change accounted for a share of
the reduction in wait times. This is supported by the finding
that planned wait times showed a marked, 68% reduction
in 2012 compared to 2010. Central-triage was recom-
mended as part of the Provincial change management strat-
egy, which likely helped to promote this transformation.
While the evidence supports early referral for high risk
CKD patients [9-12], our benchmarks also include rec-
ommendations for immediately threatening, stable, and
at risk CKD patients (priority categories 1, 3 and 4), The
need for rapid assessment is obvious for category 1 pa-
tients, but evidence supporting early referral for categories
3 and 4 is lesser [21]. Inclusion of wait time recommenda-
tions for priority 3 and 4 referrals is not intended to substi-
tute specialist assessment for appropriate CKD screening
and triage, but rather to bolster communication by estab-
lishing norms and facilitating appropriate expectations
among patients and referring colleagues.Strengths and limitations
Our study had several noteworthy strengths. We used
robust data collection methods including direct data entry
at the point of care with standardized forms. The contem-
porary time period allowed collection of representative
data including a full case mix. We also achieved a very
high nephrologist participation rate. There have been few
previous attempts to quantify waiting time I, and none foradult nephrology. The Fraser institute conducts annual
Canadian wait time surveys, which rely upon physicians’
voluntary responses to a mailed questionnaire [22]. These
data estimate median delays to medical specialist assess-
ment in BC of 2 and 4 weeks for medical oncology and
general internal medicine, respectively. Inferences based
on these studies cannot be applied to nephrology specific-
ally and are limited by lack of direct measurement as well
as low response rates (17% - 28%).
With regard to benchmarks, the process used builds
upon prior expert-opinion based benchmarking method-
ology in three ways: first, our recommendations gain
added validity because patient outcomes were monitored
through tracking the change in eGFR during the wait;
second, we measured referring physicians’ expectations
and allowed this to influence the benchmarks; third, the
benchmarks quantified a surrogate for patients’ wishes
by weighing in the nephrologists tendency to support
shorter queues when asked to assume the patient’s per-
spective. In so doing, the proposed targets acknowledge
the patient’s ‘cost’ associated with waiting. This cost is
difficult to define, though in CKD, it may include product-
ivity losses associated with absenteeism and presenteeism
[23,24] as well as the intangible psychological impact of
uncertainty when faced with a significant health concern.
Interpretation of these data must be considered in
view of certain limitations. The data collected by MOAs
may have been imprecise. We attempted to minimize
this through manual audit by a nephrologist. In cases
where the MOAs reason for referral was inconsistent
with objective data, we assigned priority according to
the objective data available (eGFR, amount of protein-
uria etc.). Moreover, data collection personnel and meth-
odology were largely the same for both cycles, making it
unlikely that MOA imprecision would have affected the
direction of overall findings.
A second limitation is that the data collection period
was relatively short. This period was the maximum that
could be negotiated in order to minimize disruption to
MOAs workflow. The duration of data collection was
also counter-balanced by a high nephrologist participa-
tion rate, which allowed a patient sample size (n = 920)
large enough to draw statistical inferences.
A third limitation is that the patient perspective re-
garding appropriate wait time was not directly evaluated.
Instead, it was weighed using the surrogate of rate at
which nephrologists revised their wait time recommen-
dations downward when assuming the patient’s perspec-
tive. The literature suggests patients are dissatisfied with
waiting and their preference is to access specialists within
the shortest possible timeframe [25,26]. Thus, we feel that
a reduction in wait time targets through the use of a sur-
rogate measure of the patient’s perspective is likely in
keeping with the direction of patients’ true wishes.
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to link nephrologists with practice groups, we were not
able to conduct a sensitivity analysis examining the impact
of group practice level variables, which might allow add-
itional conclusions to be drawn from these data.
Conclusions
An integrated, physician-led, provincial initiative to mea-
sure wait times and develop consensus waiting targets as-
sociated with improved access to outpatient nephrology
consultations in BC. Improvements in the proportion of
patients seen within recommended timeframes were most
marked for the highest priority patients, which suggests
the benchmarks had a direct influence on triaging behav-
ior. Further research is needed to determine whether this
effect is sustainable.
Future studies in this area should attempt to improve
intelligent triage of CKD patients based on adverse markers
such as proteinuria [27], newer and more accurate eGFR
equations [28,29], or novel prediction formulas to identify
progressive CKD [30]. In addition, research investigating
the link between wait times for specialist assessment with
short and long term outcomes are warranted.
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